Product Library

The BARDEX® I.C. Anti-Infective Foley catheter is clinically proven to reduce catheter-associated urinary tract infections.^1,2,3 Incorporating a technologically-advanced formulation consisting of Bacti-Guard®* silver alloy coating and BARD® hydrogel, the BARDEX® I.C. Foley catheter dramatically reduces bacterial adherence and minimises biofilm formation.

The occurrence of urinary tract infection is 3.7 times greater in patients catheterised with a standard catheter than in patients catheterised with the BARDEX® I.C. Foley catheter with Bacti-Guard®* silver alloy coating and BARD® hydrogel. (95 C.I. 2.0-6.8)

• Reduces bacterial adherence
• Minimises biofilm formation
• Inhibits migration of pathogens into the bladder
• Preserves the integrity of the urethral mucosa
• Clinically proven to reduce catheter-associated urinary tract infections ^1,2,3

BARDEX® IC will also be available within the BARD® Comprehensive Care Foley Tray range on Drug Tariff from 1st September 2010

*The Foley catheters included in the Bardex® I.C. System contain Bacti-Guard® silver alloy coating licensed from Bactiguard AB. Bacti-Guard is a registered trademark of Bactiguard AB.

Bard and Bardex are registered trademarks of C. R. Bard Inc., or an affiliate.

References

1. Maki DG, Tambyah PA. Engineering out the risk of infection with urinary catheters. Emerging Infectious Diseases. 2001; 7;342-347

2. Karchmer TB, Giannetta ET, Muto CA, Strain BA, Farr BM. A randomized crossover study of silver-coated urinary catheters in hospitalized patients. Archives of Internal Medicine. 2000; 160;3294-3298

3. Saint S, Veenstra DL, Sullivan SD, Chenoweth C, Fendrick AM. The potential clinical and economic benefits of silver alloy urinary catheters in preventing urinary tract infection. Archives of Internal Medicine. 2000; 160;2670-2675

Click here for further details

Customer Care: 01293 529555

Click here for company website